Preliminary research suggest conolidine could inhibit specific ion channels, cutting down neuronal excitability and limiting soreness signals. This system is particularly related in neuropathic discomfort, where abnormal signaling brings about persistent soreness. On top of that, conolidine seems to influence G protein-coupled receptor (GPCR) pathw